The Latest
-
CMS to delay star ratings update pending expert panel review
The agency will convene an expert panel to look at the star ratings system, which is deeply unpopular with providers, and decide whether it's due for a facelift.
-
OpinionAn important first step toward eliminating the transplant waitlist
Global Liver Institute president and CEO Donna Cryer discusses how the U.S. liver transplant system has failed patients — and how President Donald Trump's ambitious new renal care plan could help.
-
Health IT committee addresses some, but not all industry concerns with TEFCA
The advisory group recommended ONC align the HHS blueprint to foster interoperability with corresponding proposed rules to crack down on information blocking and proposed multiple incentives for industry adoption.
-
CMS proposes new home infusion therapy benefit
Home infusion therapy allows for the delivery of certain drugs, such as anti-infectives, chemotherapy or treatment for immune deficiencies, with the use of a durable medical equipment pump at a patient's home.
-
Trump executive order seeks to overhaul US kidney care
The government push for home dialysis will help major payers like UnitedHealth Group, Cigna, Anthem and Humana and interested companies like CVS Health move into the space.
UPDATED: July 10, 2019 at 1:48 p.m. -
Deep DiveACA's legal jeopardy: 4 questions
The embattled landmark law is again before jurists, this time a panel of the Fifth Circuit Court of Appeals. Arguments this week offered more insight into what's at stake.
-
FCC approves rural telehealth pilot
The three-year, $100 million program would give an 85% discount on connectivity for broadband-enabled telehealth services that directly connect doctors and patients.
-
White House pulls drug rebate rule to relief of payers
Withdrawal of the rule, which drugmakers supported, puts greater focus on the administration's plans for an international price index for certain doctor-administered drugs.
-
Female health CIOs defy trend, earn more than men, survey finds
Health IT executive salaries have risen since 2012, and women make roughly $30,000 more than their male counterparts, according to a College of Healthcare Information Management Executives survey.
-
Health sector in better place to weather recession than in 2008, analysis finds
Providers would have less exposure to uncompensated care because of expanded Medicaid and ACA subsidies, according to McKinsey. Still, the report projects an earnings hit between 5%-20% for payers and 5%-30% for providers.
-
Appeals court judge on ACA: 'Congress can fix this'
Two Republican-appointed judges hammered Democrats on whether the ACA's individual mandate was severable from the rest of the law and asked why Congress expected them to find a solution.
-
UnitedHealth backs Inspire Medical's sleep apnea implant
The massive private payer deemed the Minnesota medtech's neurostimulation system medically necessary in patients with obstructive sleep apnea who have already tried CPAP therapy.
-
Air ambulance industry on defense as surprise billing debate heats up
Emergency air service providers are warning of base closures if surprise billing legislation working its way through Congress passes.
-
Beaumont, Summa sign letter of intent to merge
A Beaumont spokesman said the organizations will buy out Mercy Health's minority stake in Summa, but exact terms of the deal are not being disclosed. It is expected to be finalized by the end of this year.
-
Amazon momentum in medical supply chain slows, poll finds
A UBS survey of hospital purchasing managers found providers are allocating a smaller percentage of such purchases to the retail giant this year.
-
UK testing Netflix-style payments to boost antibiotics development
Officials hope the model will overcome some of the obstacles that have stifled the commercial prospects for new antibiotics.
-
SponsoredIncreasing member engagement while reducing the risk of a costly data breach
Do you have all the necessary layers of security to protect your members and ensure compliance?
-
Healthcare Dive's 10 biggest stories of the spring
From Amazon pushing into the prescription delivery sector to CVS-Aetna struggling to finalize their merger settlement agreement, read the top stories from the first half of the year.
-
Republican bid to dismantle ACA takes center stage
A federal appeals court in New Orleans heard oral arguments Tuesday in a ruling that could send ripples across the industry.
-
In win for pharma, Trump TV drug price rule struck down
The federal district court sided with a drugmaker coalition that argued the government overstepped its authority in trying to force price transparency in advertisements.
-
Pharma stocks slide as industry mulls Trump drug price action
Drug pricing is back in the spotlight as politicians grapple with ways to bring down healthcare costs. While the meaning of the president's comments wasn't clear, Monday's market reaction was unambiguous.
-
DOJ, House, states tell appeals court it has authority to hear ACA case
Ahead of Tuesday's oral argument, parties in the appeal over the constitutionality of the Affordable Care Act filed briefs telling the court it has jurisdiction because a live controversy exists.
-
Air Methods, Global Medical Response most at risk with surprise billing ban
Large air ambulance companies have the most to lose should a ban on balance billing become law, a new report says.
-
Deep DiveCould NEMT's pivot to the commercial sector be a wrong turn?
Employers and commercial plans are increasingly looking to partner with players like Uber and Lyft for non-emergency medical transportation, raising thorny questions about the return on investment in a healthier population.
-
Zolgensma set a new drug pricing bar. Insurers show some signs of pushback
One month after approval, a handful of payers — including Anthem — have adopted policies taking a more cautious stance than what the FDA set out in the gene therapy's label.
